In plain language
Tripeptide-29 is a synthetic three amino acid peptide used in anti-aging skincare and marketed to support collagen and a firmer-looking complexion. Most supporting data is in-vitro or manufacturer-sponsored, so independent human evidence is sparse.
What it is explored for
Tripeptide-29 is modeled on a repeating sequence found in collagen, which gives it a natural appeal for firming-focused routines. Most support is in-vitro or manufacturer-based and independent human data are sparse, so it is best explored as a gentle supporting ingredient rather than a proven collagen booster.
- A firmer-looking complexion
- Support for the skin's natural collagen-related activity
- Smoother-looking fine lines
- Overall skin texture and resilience
- Daily anti-aging serums and creams
These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary evidence rating, see the evidence summary below for how strong the science actually is.
How it works
Tripeptide-29 is marketed as a collagen-related peptide. The rationale draws on a repeating sequence found in collagen and the idea that it supports matrix activity.
- Collagen-mimetic rationale. It is described as based on a glycine-proline-hydroxyproline style motif found in collagen, marketed to support collagen-related activity in skin.
- Topical delivery question. How much reaches the target through intact skin is uncertain, a common limitation for cosmetic peptides.
- Surface conditioning. Part of any perceived firmness may reflect hydration and film-forming effects of the formulation.
The proposed mechanism rests on in-vitro work and manufacturer rationale rather than robust independent human data.
Evidence summary
Independent human evidence for tripeptide-29 is sparse, with most support from in-vitro work and manufacturer materials. Any firming or collagen benefit should be regarded as preliminary.
Reported safety & side effects
Tripeptide-29 is generally considered well tolerated in leave-on cosmetics at typical use levels. Independent long-term safety data are sparse.
Frequently asked
What is tripeptide-29 marketed to do?
It is marketed to support collagen-related activity and a firmer-looking complexion, based on a sequence modeled on collagen.
Is the collagen benefit proven in people?
No. Support comes mostly from in-vitro work and manufacturer materials, so the evidence in living human skin is preliminary.